Cara Therapeutics reported $-30876000 in Operating Profit for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Acadia Pharmaceuticals ACAD:US $ -43.71M 23.06M
Acelrx Pharmaceuticals ACRX:US $ -10015000 873K
Aerie Pharmaceuticals AERI:US $ -31.5M 2.72M
Antares Pharma ATRS:US $ 6.79M 1.4M
Arena Pharmaceuticals ARNA:US $ -144.39M 12.4M
Biodelivery Sciences International BDSI:US $ 15.66M 8.22M
Cara Therapeutics CARA:US $ -30876000 7.32M
Chugai Pharma 4519:JP Y 96712M 32745M
Depomed DEPO:US $ -12M 19.51M
Endo International Ordinary Shares ENDP:US $ 143.1M 39.58M
Halozyme Therapeutics HALO:US $ 93.05M 63.27M
Horizon Pharma HZNP:US $ 138.51M 298.53M
JAZZ PHA JAZZ:US $ -69.59M 231.71M
Johnson & Johnson JNJ:US $ 3849M 2813M
Neurocrine Biosciences NBIX:US $ 62.8M 31.3M
Pacira Pharmaceuticals PCRX:US $ 34.84M 15.41M
Pain Therapeutics PTIE:US $ -5138000 1.6M
Pfizer PFE:US $ 5914M 397M
Redhill Biopharma RDHL:US $ -24.89M 6.73M
Revance Therapeutics RVNC:US $ -70337000 325K
Supernus Pharmaceuticals SUPN:US $ 34.11M 20.9M
Teva Pharmaceutical Industries TEVA:US $ 582M 148M
Vanda Pharmaceuticals VNDA:US $ 12.37M 2.03M